Literature DB >> 11283941

Alternative medicine use worldwide: the International Union Against Cancer survey.

B R Cassileth1, S Schraub, E Robinson, A Vickers.   

Abstract

BACKGROUND: In the current study, the authors attempted to surmount the deficiencies of previous surveys and elicit information regarding the use of alternative treatments of cancer worldwide.
METHODS: The International Union Against Cancer (UICC), an international, nongovernment volunteer organization, E-mailed a questionnaire concerning alternative therapy use to its members.
RESULTS: A total of 83 responses from 33 countries were received. Descriptive analyses of this dataset were conducted, indicating the existence of a large and heterogeneous group of unproved remedies used to treat cancer in both developed and developing countries around the world.
CONCLUSIONS: Improved public education concerning the importance of early medical attention and the value of documented cancer therapies, the wider availability of useful cancer treatments, and public policies that are sensitive to the patient's need to play a meaningful role in his or her own care are required. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11283941     DOI: 10.1002/1097-0142(20010401)91:7<1390::aid-cncr1143>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

Review 1.  [Chemoprevention of prostate cancer].

Authors:  B Djavan; I Thompson; M S Michel; M Waldert; C Seitz
Journal:  Urologe A       Date:  2004-05       Impact factor: 0.639

2.  Genistein and genistein-containing dietary supplements accelerate the early stages of cataractogenesis in the male ICR/f rat.

Authors:  Kyle A Floyd; David R Stella; Chao-Cheng Wang; Sara Laurentz; George P McCabe; Om P Srivastava; Stephen Barnes
Journal:  Exp Eye Res       Date:  2010-12-10       Impact factor: 3.467

3.  Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study.

Authors:  Eunyoung Kang; Eun Joo Yang; Sun-Mi Kim; Il Yong Chung; Sang Ah Han; Do-Hoon Ku; Soek-Jin Nam; Jung-Hyun Yang; Sung-Won Kim
Journal:  Support Care Cancer       Date:  2011-01-28       Impact factor: 3.603

4.  Use of complementary and alternative medicine by cancer patients at Zhejiang University Teaching Hospital Zhuji Hospital, China.

Authors:  Lisong Teng; Ketao Jin; Kuifeng He; Chunge Bian; Weili Chen; Kaiyan Fu; Tieming Zhu; Zhigang Jin
Journal:  Afr J Tradit Complement Altern Med       Date:  2010-07-03

5.  Integrating Yoga in Oncology: Is the wait over?

Authors:  Nagarathna Raghuram; Raghavendra M Rao; H R Nagendra
Journal:  Indian J Surg Oncol       Date:  2016-03-03

6.  Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD.

Authors:  Agnete E Kristoffersen; Arne J Norheim; Vinjar M Fønnebø
Journal:  BMC Complement Altern Med       Date:  2012-01-12       Impact factor: 3.659

7.  The behaviors of seeking a second opinion from other health-care professionals and the utilization of complementary and alternative medicine in gynecologic cancer patients.

Authors:  K F Tam; D K L Cheng; T Y Ng; H Y S Ngan
Journal:  Support Care Cancer       Date:  2005-07-20       Impact factor: 3.603

8.  Use of complementary and alternative therapies: a national multicentre study of oncology health professionals in Norway.

Authors:  A Kolstad; T Risberg; Y Bremnes; T Wilsgaard; H Holte; O Klepp; O Mella; E Wist
Journal:  Support Care Cancer       Date:  2004-02-06       Impact factor: 3.603

9.  The association between mental distress and the use of alternative medicine among cancer patients in North Norway.

Authors:  T Risberg; B K Jacobsen
Journal:  Qual Life Res       Date:  2003-08       Impact factor: 4.147

10.  Depression and the use of complementary medicine among breast cancer patients.

Authors:  Ali Montazeri; Akram Sajadian; Mandana Ebrahimi; Mohammad Esmail Akbari
Journal:  Support Care Cancer       Date:  2004-11-12       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.